Therapeutics utilising Natural Killer Cells target numerous pathogenic antigens with effective cytotoxicity and lower the danger of cytokine storms. They can be made from a multitude of sources without relying on immune cells that are unique to a patient. Currently, a number of methods have been established to increase the efficacy of NK cells therapies, such as ex vivo pre-conditioning with cytokines or small molecular medicines and creating a chimeric antigen receptor (CAR) NK.
read more..